- Home
- CCM vs INKT Comparison
CCM vs INKT Comparison
Compare CCM & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- INKT
- Stock Information
- Founded
- CCM 1997
- INKT 2017
- Country
- CCM China
- INKT United States
- Employees
- CCM N/A
- INKT N/A
- Industry
- CCM Medical/Nursing Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- CCM Health Care
- INKT Health Care
- Exchange
- CCM Nasdaq
- INKT Nasdaq
- Market Cap
- CCM 33.3M
- INKT 28.8M
- IPO Year
- CCM 2009
- INKT 2021
- Fundamental
- Price
- CCM $5.25
- INKT $62.86
- Analyst Decision
- CCM
- INKT Strong Buy
- Analyst Count
- CCM 0
- INKT 2
- Target Price
- CCM N/A
- INKT $37.50
- AVG Volume (30 Days)
- CCM 1.8K
- INKT 2.4M
- Earning Date
- CCM 04-25-2025
- INKT 08-12-2025
- Dividend Yield
- CCM N/A
- INKT N/A
- EPS Growth
- CCM N/A
- INKT N/A
- EPS
- CCM N/A
- INKT N/A
- Revenue
- CCM $52,603,198.00
- INKT N/A
- Revenue This Year
- CCM N/A
- INKT N/A
- Revenue Next Year
- CCM N/A
- INKT N/A
- P/E Ratio
- CCM N/A
- INKT N/A
- Revenue Growth
- CCM N/A
- INKT N/A
- 52 Week Low
- CCM $3.80
- INKT $4.56
- 52 Week High
- CCM $10.50
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- CCM 33.93
- INKT 57.39
- Support Level
- CCM $5.50
- INKT $6.80
- Resistance Level
- CCM $5.68
- INKT $7.88
- Average True Range (ATR)
- CCM 0.18
- INKT 0.40
- MACD
- CCM 0.00
- INKT 0.02
- Stochastic Oscillator
- CCM 21.79
- INKT 58.86
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.